Trevena, Inc. ( TRVN) - Key Metrics
TRVN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.33 | -$5.79 | -$5.28 | -$5.28 |
| 2024Q2 | $0.38 | -$5.74 | -$8.42 | -$8.42 |
| 2024Q1 | $0 | -$0.36 | -$0.44 | -$0.44 |
| 2023Q4 | -$0.01 | -$1.16 | -$0.42 | -$0.42 |
| 2023Q3 | $0.01 | -$0.56 | -$0.63 | -$0.63 |
TRVN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -0.16 |
| 2024Q2 | ? | -0.23 |
| 2024Q1 | ? | -6.94 |
| 2023Q4 | ? | -3.88 |
| 2023Q3 | ? | -6.74 |
TRVN
Price: $0.01
52 week price:
Earnings Per Share: -48.89 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 42100
Ebitda: -15.1 millionMarket Capitalization: 1728